Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;176(4):1564-76.
doi: 10.2353/ajpath.2010.090786. Epub 2010 Feb 18.

Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors

Affiliations
Review

Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors

Seth B Coffelt et al. Am J Pathol. 2010 Apr.

Abstract

It is now established that bone marrow-derived myeloid cells regulate tumor angiogenesis. This was originally inferred from studies of human tumor biopsies in which a positive correlation was seen between the number of tumor-infiltrating myeloid cells, such as macrophages and neutrophils, and tumor microvessel density. However, unequivocal evidence was only provided once mouse models were used to examine the effects on tumor angiogenesis by genetically or pharmacologically targeting myeloid cells. Since then, identifying the exact myeloid cell types involved in this process has proved challenging because of myeloid cell heterogeneity and the expression of overlapping phenotypic markers in tumors. As a result, investigators often simply refer to them now as "bone marrow-derived myeloid cells." Here we review the findings of various attempts to phenotype the myeloid cells involved and discuss the therapeutic implications of correctly identifying-and thus being able to target-this proangiogenic force in tumors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Various myeloid-lineage cell types implicated to date in the regulation of tumor angiogenesis. Markers expressed (or not expressed) by each of the distinct cell types are indicated. Note that several markers are coexpressed by different myeloid cell types, raising the question of whether some of these represent distinct cell types, rather then overlapping cell subsets or differentiation states of a same cell type.
Figure 2
Figure 2
A schematic illustrating the possible relationships among monocyte/macrophage subpopulations found in tumors. Tumor-infiltrating macrophages are known to derive from circulating CCR2+ inflammatory monocytes; however, it remains to be investigated whether inflammatory monocytes give raise to each of the distinct macrophage subpopulations found in tumors. The contribution of CCR2–resident monocytes to tumor macrophages is currently unknown. Dashed arrows indicate putative developmental relationships.

Similar articles

Cited by

References

    1. Ahn GO, Brown JM. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow–derived myelomonocytic cells. Cancer Cell. 2008;13:193–205. - PMC - PubMed
    1. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. HIF1alpha induces the recruitment of bone marrow–derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008;13:206–220. - PMC - PubMed
    1. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006;66:11238–11246. - PubMed
    1. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 2001;193:727–740. - PMC - PubMed
    1. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell. 2005;8:211–226. - PubMed

Publication types